Concepedia

Shigeru Matsuura

SM

4

Publications

192

Citations

4

H-Index

2004

Active since

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Shigeru Matsuura is an author at Mitsubishi Tanabe Pharma Corporation specializing in medicine, neuroprotection, and cerebral blood flow.

Top concepts

Publications per year

2004–2011

4

Publications

4

A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2 H)-pyridinyl)propyl]-4(3 H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia

Akinori Iwashita, Nobuteru Tojo, Shigeru Matsuura et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 82 citations

MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model

Shigeru Matsuura, Yasuhiro Egi, Satoshi Yuki et al. · Brain Research · 2011 · 45 citations

, , +12

A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice

Akinori Iwashita, Kayoko Mihara, Syunji Yamazaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 41 citations

Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia

Yasuhiro Egi, Shigeru Matsuura, Tomoyuki Maruyama et al. · Brain Research · 2011 · 24 citations

, , +13

Rows per page

1–4 of 4